In this review, we present and discuss evidence for the role of mTOR in the progression of NAFLD; data indicate that mTOR regulates NAFLD progression through lipid metabolism, IR, OS, intestinal flora, autophagy, the inflammatory response, genetic polymorphisms, and epigenetics. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.